- Preview Available
- Scholarly Journal
The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinoma
The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinomaScientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 7069.
DOI:10.1038/s41598-025-90574-3
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.




